期刊文献+

肿瘤标志物联合检测在肺癌诊断中的价值 被引量:17

The diagnostic value of tumor's markers conjoined detection for lung cancer
暂未订购
导出
摘要 目的探讨肿瘤标记物CEA、CA-50、CA242、CA125、NSE在肺癌诊断中的价值。方法应用时间分辨荧光免疫法测定45例肺癌、31例肺良性病变、28例经体检证明是健康人的血清肿瘤标记物水平。结果肺癌患者五项血清肿瘤标记物浓度均高于肺良性病变及健康组(P<0.01,P<0.05)。敏感性分别是CEA42.4%(19/45),CA-50 40.4%(18/45),CA242 33.3%(15/45),CA125 28.9%(13/45)、NSE 26.7%(12/45),联合检测敏感性达到91.1%。结论联合检测CEA、CA-50、CA242、CA125、NSE可以显著提高肺癌血清肿瘤标记物的敏感性和特异性,为肺癌诊断提供科学的方法和依据。 Objective To search the diagnostic value of the conjoined detection method for tumor markers CEA,CA-50,CA242, CA125 and NSE for lung cancer.Methods Choose 45 cases of lung cancer, benign lung diseases 31 cases and 21 health persons as control group. Then apply time distinguish fluorescence immunity technique to determine the level of tumor markers in the blood serum. Results The concentrations of the five tumor markers in the cancer patients group are higher than that of the benign lung diseases group and the health control group ( P 〈 0.01 and P 〈 0.05) .The sensitivities are CEA 68.9% (31/45), CA-50 66.7% (30/ 45), CA242 55.6%(25/45), CA125 48.9%(22/45) and NSE 44.4% (20/45) respectively. However, the sensitivity of combing detection achieves 95.6 % (43/45). Conclusion The conjoined detection of CEA, CA-50, CA242, CA125 and NSE prornote distinctively the sensitivity and specificity for lung cancer patients, which will provide a scientific and reliable method for diagnosis of lung cancer.
出处 《中国实验诊断学》 2006年第7期774-776,共3页 Chinese Journal of Laboratory Diagnosis
关键词 肿瘤标志物 肺癌 诊断 tumor marker lung cancer diagnosis
  • 相关文献

参考文献7

  • 1叶任高.内科学[M].第5版.北京:人民卫生出版社,2001:123.
  • 2顾宗元,胡宏,王磊,刘欣艳.影响肺癌相关肿瘤标志物因素分析[J].临床肺科杂志,2003,8(1):11-12. 被引量:10
  • 3Nonaka M,Kataoka D,Yamamoto S,et al.Pre-and post-operative serum carcinoembryonic antigen in primary lung adenocarcinoma[J].Ann Thorac Cardiovasc Surg,2004,10(5):281.
  • 4Castaldo G,Tomaiuolo R,Sanduzzi A,et al.Carcinoembryonic antigen mRNA analysis detects micrometastatic cell in blood from lung cancer patients[J].Eur Respir J.2003,22(3):418.
  • 5杨辰,吾为一,吴锦昌.多项血清肿瘤标志物联合检测在肺癌诊断中的价值[J].标记免疫分析与临床,2004,11(2):71-73. 被引量:30
  • 6Pollan M,Varela G,Torres A,et al.Clinical value of p53,c-erbB-2,CEA and CA125 regarding relapse,metastasis and death in resectable non-small cell lung cancer[J].Int J Cancer,2003,107(5):781.
  • 7Kulpa J,Wojcik E,Reinfuss M,et al.Carcinoembryonic antigen,squamous cell carcinoma antigen,CYFRA 21-1,and neuron-specific enolase in squamous cell lung cancer patients[J].Clin Chem.2002,48(11):1931.

二级参考文献10

  • 1Teresa C P, Isabel T Z, Juan B L, et al. Tumour markers in lung cancer: does the method of obtaining the cut - off point and reference population influence diagnostic yield? [ J ]. Clinical Biochemistry, 1999, 32:467 - 472.
  • 2Ho Y J, Hsieh J F, Tasi S C, et al. Tissue polypeptide specific antigen and squamous cell carcinoma antigen for early prediction of recurrence in lung squamous cell carcinoma[J] .Lung, 2000, 178:75 - 80.
  • 3Bates J, Rutherford M, Divilly M, et al. Clinical value of CYFRA21- 1, carcinoembryonic antigen and tissue polypeptideantigen in the diagnosis of lung cancer[J ]. Eur Respir J, 1997,10:2535 - 3538.
  • 4Manual D, Antonio T, Marina P, et al. Prognostic significance of serum CA125 antigen assay in patients with non - small cell lung cancer[J ]. Cancer, 1994, 73:1368 - 1376.
  • 5Reinsber J. Different efficacy of various blocking reagents to eliminate interference by human anti-bodies with site immunoassay. Clinical biolchemistry. 1999; 29:145~148.
  • 6Hasholzner U,et al. Value of HAMA-determination in clnical practice-anoverview,Anticancer Research, 1997 ; 170: 3035~3058.
  • 7况成明,陈启福.三种肿瘤标记物联合检测对肺癌临床应用价值的探讨[J].中国肿瘤临床,2000,27(5):388-388. 被引量:40
  • 8李春海.加强肿瘤生物学标志的研究和评价[J].中华检验医学杂志,2000,23(1):6-8. 被引量:101
  • 9黄学文,赵琪.人抗小鼠抗体对CA199检测的影响[J].临床检验杂志,2001,19(6):357-358. 被引量:1
  • 10陈名声,刘建新,于文彬.组织多肽特异性抗原与肺癌关系的研究进展[J].中华检验医学杂志,2003,26(1):56-57. 被引量:7

共引文献38

同被引文献99

引证文献17

二级引证文献84

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部